REPORT DA DDW 2026 (2-5 MAGGIO). I 3 PAPER PIU’ INTERESSANTI SECONDO D.A.JOHNSON. ED ANCHE PER NOI. DA”MEDSCAPE” (FREE)

EPATOLOGIA, GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI

Digestive Disease Week (DDW) 2026 Highlights: Part 2 David A. Johnson, MD Professor of medicine and chief of gastroenterology at Eastern Virginia Medical School/Macon & Joan Brock Virginia Health Sciences at Old Dominion University in Norfolk, Virginia.  Spontaneous Bacterial Peritonitis (SBP) Care Shows Gaps In 2021, the American Association for the Study of Liver Diseases…

AGONISTI DEI RECETTORI DEL GLUCAGONE GLP-1. CARE AMICHE ED AMICI E’ TEMPO CHE IMPARIAMO A PRESCRIVERLI NOI. UN’OTTIMA REVIEW DA “The New England Journal of Medicine” (FREE)

EPATOLOGIA, GASTROENTEROLOGIA, MEDICINA INTERNA, NEWSLETTER, NUTRIZIONE

GLP-1 Receptor Agonists Clifford J. Rosen, M.D.,and Julie R. Ingelfinger, M.D. Summary Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic peptide agonists have several mechanisms of action, including reduction of gastric…

ESOFAGITE EOSINOFILA: BIOLOGICI VS STEROIDI. UNA GRANDE NETWORK META-ANALISI! DA “Clinical Gastroenterology and Hepatology”

ENDOSCOPIA, GASTROENTEROLOGIA, NEWSLETTER, NUTRIZIONE

Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients With Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis With Meta-Regression Mohammad Al Hayek et al. Abstract Background & Aims The therapeutic hierarchy of current pharmacologic options for eosinophilic esophagitis (EoE) has not been established. We performed a network meta-analysis to evaluate the comparative efficacy…